Tardive dyskinesia (TD) is an involuntary movement disorder caused by long-term dopamine-blocking medications. Prolonged use may create chemical imbalances in brain areas controlling movement.
The research team of the Neurology Department Movement Disorders Unit at the Virgen del Rocío University Hospital and the Movement Disorders group of the Institute of Biomedicine of Seville - IBiS, in ...
Recent discoveries made by researchers from Charité – Universitätsmedizin Berlin may prove vital in improving the treatment of dystonia, a neurological movement disorder. Published in PNAS, their ...
Our division consists of movement disorder specialists with expertise in the full range of neurological disorders that affect movement, such as Parkinson disease and other Parkinsonian disorders, ...
Incubated by Atlas Venture, the biotech startup is advancing a daily pill it sees potentially helping people with dystonia or ...
Tardive dyskinesia (TD) is a rare movement disorder linked to long-term use of certain medications, especially dopamine receptor-blocking drugs like antipsychotics. Early TD symptoms often start with ...
Stereotypic movement disorder is a motor disorder that develops in childhood, typically before grade school, and involves repetitive, purposeless movement. Examples of stereotypic movements include ...
A 59-year-old woman with a background of HIV living with an uncontrollable movement disorder presented to Eoghan Donlon, MB, BCh BAO, MRCPI, of the Mater Misericordiae University Hospital in Dublin, ...
Please provide your email address to receive an email when new articles are posted on . Neurocrine Biosciences Inc. recently presented data on comorbidities, polypharmacy and treatment patterns of ...
Neurological disorders affect over a third of the global population, presenting immense challenges for patients worldwide. Merz Therapeutics, a leading player in specialty neurology, aims to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results